Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    May 2019
  1. ISSA F
    Proteomics Identifies New Therapeutic Targets of Early-stage Hepatocellular Carcinoma.
    Transplantation. 2019;103:855-856.
    PubMed     Text format    


    April 2019
  2. LIU Y, Lu T, Zhang C, Xue Z, et al
    Pituitary Adenylate Cyclase-Activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia/Reperfusion Injury.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002742.
    PubMed     Text format     Abstract available


  3. ATIEMO K, Mazumder NR, Caicedo JC, Ganger D, et al
    The Hispanic Paradox in Patients with Liver Cirrhosis: Current Evidence from a Large Regional Retrospective Cohort Study.
    Transplantation. 2019 Apr 2. doi: 10.1097/TP.0000000000002733.
    PubMed     Text format     Abstract available


  4. EBADI M, Bhanji RA, Montano-Loza AJ
    Ethnic Disparities in the Prognosis of Cirrhosis.
    Transplantation. 2019 Apr 2. doi: 10.1097/TP.0000000000002734.
    PubMed     Text format    


  5. IONESCU MI, Tillakaratne S, Hodson J, Gunson B, et al
    Normothermic Machine Perfusion Enhances Intraoperative Hepatocellular Synthetic Capacity: A Propensity-Score Matched Analysis.
    Transplantation. 2019 Apr 1. doi: 10.1097/TP.0000000000002720.
    PubMed     Text format     Abstract available


    March 2019
  6. GUSTAFSON E, Hamad OA, Deckmyn H, Barbu A, et al
    Exposure of von Willebrand factor on isolated hepatocytes promotes tethering of platelets to the cell surface.
    Transplantation. 2019 Mar 21. doi: 10.1097/TP.0000000000002707.
    PubMed     Text format     Abstract available


    February 2019
  7. GORGEN A, Rosales R, Sadler E, Beecroft R, et al
    Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002616.
    PubMed     Text format     Abstract available


  8. RHU J, Kim JM, Choi GS, Hyuck C, et al
    The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002601.
    PubMed     Text format     Abstract available


  9. KOC C, Akbulut S, Ozdemir F, Kose A, et al
    Analysis of Risk Factors Affecting the Development of Infection in Artificial Vascular Grafts Used for Reconstruction of Middle Hepatic Vein Tributaries in Living Donor Liver Transplantation.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002583.
    PubMed     Text format     Abstract available


  10. CHEN K, Sheng J, Ma B, Cao W, et al
    Suppression of hepatocellular carcinoma by mycophenolic acid in experimental models and in patients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002647.
    PubMed     Text format     Abstract available


    November 2018

  11. Analysis of Differentially Expressed Proteins in Hepatocellular Carcinoma: Erratum.
    Transplantation. 2018 Nov 12. doi: 10.1097/TP.0000000000002534.
    PubMed     Text format    


  12. PAUL S, Charlton M
    Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
    Transplantation. 2018 Nov 5. doi: 10.1097/TP.0000000000002513.
    PubMed     Text format    


    October 2018
  13. YOUNOSSI ZM, Marchesini G, Pinto-Cortez H, Petta S, et al
    Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002484.
    PubMed     Text format     Abstract available


  14. RATZIU V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G, et al
    Recommendations for management and treatment of nonalcoholic steatohepatitis.
    Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002483.
    PubMed     Text format     Abstract available


  15. LU WY, Forbes SJ
    Telomerase Activity Links to Regenerative Capacity of Hepatocytes.
    Transplantation. 2018;102:1587-1588.
    PubMed     Text format    


    August 2018
  16. TSOCHATZIS E, Coilly A, Nadalin S, Levistky J, et al
    International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.
    Transplantation. 2018 Aug 27. doi: 10.1097/TP.0000000000002433.
    PubMed     Text format     Abstract available


  17. MOON JI, Schiano TD, Burnham A, Lam K, et al
    Small-for-size Syndrome Does Not Occur in Intestinal Transplantation Without Liver Containing Grafts.
    Transplantation. 2018;102:1300-1306.
    PubMed     Text format     Abstract available


    July 2018
  18. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed     Text format    


  19. BARBIER L, Bucur P, Salame E
    Extended-criteria allografts a strategy to reduce waiting list mortality in selected hepatocellular carcinoma recipients.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002365.
    PubMed     Text format    


  20. HEITS N, Brosch M, Herrmann A, Behrens R, et al
    EVOLUTIONARY DISTANCE PREDICTS RECURRENCE AFTER LIVER TRANSPLANTATION IN MULTIFOCAL HEPATOCELLULAR CARCINOMA.
    Transplantation. 2018 Jul 9. doi: 10.1097/TP.0000000000002356.
    PubMed     Text format     Abstract available


  21. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Text format     Abstract available


  22. DOMEN J
    Minimally invasive transplantation of primary human hepatocyte inserts that facilitate vascularization.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002331.
    PubMed     Text format    


  23. CROOME KP, Mathur AK, Lee DD, Moss AA, et al
    Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Transplantation. 2018;102:1108-1114.
    PubMed     Text format     Abstract available


  24. LEE KW, Han S, Lee S, Cha HH, et al
    Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity.
    Transplantation. 2018;102:1115-1123.
    PubMed     Text format     Abstract available


    June 2018
  25. SEALE N, Ramaswamy S, Shih YR, Verma I, et al
    Macroporous dual compartment hydrogels for minimally invasive transplantation of primary human hepatocytes.
    Transplantation. 2018 Jun 18. doi: 10.1097/TP.0000000000002330.
    PubMed     Text format     Abstract available


  26. IMAI D, Yoshizumi T, Sakata K, Ikegami T, et al
    Long-term outcomes and risk factors after adult living donor liver transplantation.
    Transplantation. 2018 Jun 13. doi: 10.1097/TP.0000000000002324.
    PubMed     Text format     Abstract available


  27. MIYAAKI H, Miuma S, Taura N, Shibata H, et al
    Risk factors and clinical course for liver steatosis or nonalcoholic steatohepatitis after living donor liver transplantation.
    Transplantation. 2018 Jun 11. doi: 10.1097/TP.0000000000002319.
    PubMed     Text format     Abstract available


    May 2018
  28. DURAND F, Francoz C, Asrani SK, Khemichian S, et al
    Acute Kidney Injury after Liver Transplantation.
    Transplantation. 2018 May 29. doi: 10.1097/TP.0000000000002305.
    PubMed     Text format     Abstract available


  29. LI F, Jiao A, Li X, Zhang C, et al
    Survival and Metabolic Function of Syngeneic Mouse Islet Grafts Transplanted into the Hepatic Sinus-tract.
    Transplantation. 2018 May 22. doi: 10.1097/TP.0000000000002289.
    PubMed     Text format     Abstract available


  30. RODRIGUEZ-PERALVAREZ M, Guerrero M, Barrera L, Ferrin G, et al
    Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transplantation. 2018 May 11. doi: 10.1097/TP.0000000000002270.
    PubMed     Text format     Abstract available


  31. PARKER A, Karvellas CJ
    Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.
    Transplantation. 2018 May 7. doi: 10.1097/TP.0000000000002273.
    PubMed     Text format     Abstract available


  32. MARCON F, Schlegel A, Bartlett DC, Kalisvaart M, et al
    Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft Use.
    Transplantation. 2018;102:e211-e218.
    PubMed     Text format     Abstract available


    April 2018
  33. LIKHITSUP A, Helzberg JH, Alba LM, Larkin MK, et al
    Persistent Alpha-galactosidase A Deficiency following Simultaneous Liver-Kidney Transplantation in a Patient with Fabry Disease.
    Transplantation. 2018 Apr 24. doi: 10.1097/TP.0000000000002257.
    PubMed     Text format    


  34. HOGEN R, Lo M, DiNorcia J, Ji L, et al
    More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Transplantation. 2018 Apr 18. doi: 10.1097/TP.0000000000002248.
    PubMed     Text format     Abstract available


  35. HONDA M, Sugawara Y, Kadohisa M, Shimata K, et al
    Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002197.
    PubMed     Text format     Abstract available


  36. ALLEN AM, Heimbach JK, Larson JJ, Mara KC, et al
    Reduced access to liver transplantation in women: role of height, MELD exception scores and renal function underestimation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002196.
    PubMed     Text format     Abstract available


  37. SPENGLER EK
    The Author's Reply.
    Transplantation. 2018;102:e189-e190.
    PubMed     Text format    


    March 2018
  38. VANWAGNER LB, Montag S, Zhao L, Allen NB, et al
    Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002175.
    PubMed     Text format     Abstract available


    February 2018
  39. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Text format     Abstract available


  40. CHARLTON M, Levitsky J, Aqel B, O'Grady J, et al
    International Liver Transplant Society Consensus Statement on IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002147.
    PubMed     Text format    


  41. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002136.
    PubMed     Text format     Abstract available


  42. THULUVATH AJ, Chen PH, Thuluvath PJ, Kantsevoy S, et al
    Poor Survival after Retransplantation in NASH cirrhosis.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002135.
    PubMed     Text format     Abstract available


  43. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    PubMed     Text format     Abstract available


  44. SHIRABE K, Eguchi S, Okajima H, Hasegawa K, et al
    Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.
    Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126.
    PubMed     Text format     Abstract available


  45. SAVALE L, Duclos-Vallee JC, Sitbon O
    Outcome of portopulmonary hypertension after liver transplantation: perhaps not so optimistic.
    Transplantation. 2018 Feb 2. doi: 10.1097/TP.0000000000002112.
    PubMed     Text format    


    January 2018
  46. QUARELLO P, Tandoi F, Carraro F, Vassallo E, et al
    Successful sequential liver and haematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002114.
    PubMed     Text format     Abstract available


  47. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Text format     Abstract available


  48. BEZINOVER D, Dirkmann D, Findlay J, Guta C, et al
    Perioperative Coagulation Management in Liver Transplant Recipients.
    Transplantation. 2018 Jan 15. doi: 10.1097/TP.0000000000002092.
    PubMed     Text format     Abstract available


  49. ECKER BL, Hoteit MA, Forde KA, Hsu CC, et al
    Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002056.
    PubMed     Text format     Abstract available


  50. SADLER EM, Mehta N, Bhat M, Ghanekar A, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002043.
    PubMed     Text format     Abstract available


  51. YAO S, Yagi S, Uozumi R, Iida T, et al
    A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002047.
    PubMed     Text format     Abstract available


  52. GIRETTI G, Barbier L, Bucur P, Marques F, et al
    Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002069.
    PubMed     Text format     Abstract available


    December 2017
  53. IANNELLI A, Schiavo L
    Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002065.
    PubMed     Text format    


  54. SPENGLER EK
    The Author's Reply: Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002064.
    PubMed     Text format    


  55. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Text format     Abstract available


    November 2017
  56. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Text format     Abstract available


  57. LI CX, Man K, Lo CM
    The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
    Transplantation. 2017;101:2665-2670.
    PubMed     Text format     Abstract available


  58. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed     Text format    


    October 2017
  59. REYMOND M, Barbier L, Salame E, Besh C, et al
    Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001981.
    PubMed     Text format     Abstract available


  60. ZHU J, Chen PY, Frankel M, Selby RR, et al
    Contemporary Policies Regarding Alcohol and Marijuana use Among Liver Transplant Programs in the United States.
    Transplantation. 2017 Oct 10. doi: 10.1097/TP.0000000000001969.
    PubMed     Text format     Abstract available


  61. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Text format     Abstract available


  62. WENG J, Li W, Jia X, An W, et al
    Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Transplantation. 2017;101:2340-2348.
    PubMed     Text format     Abstract available


  63. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Text format     Abstract available


    September 2017
  64. WONG LL, Truong HP, Seto T, Lacar L, et al
    Marked decrease in urgent listing for liver transplantation over time: evolution of characteristics and outcomes of Status-1 liver transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001967.
    PubMed     Text format     Abstract available


  65. CITRO A, Cantarelli E, Pellegrini S, Dugnani E, et al
    Antiinflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models.
    Transplantation. 2017 Sep 8. doi: 10.1097/TP.0000000000001925.
    PubMed     Text format     Abstract available


  66. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Text format     Abstract available


  67. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Text format     Abstract available


    August 2017
  68. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Text format     Abstract available


  69. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Text format     Abstract available


  70. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Text format     Abstract available


  71. STINE JG, Intagliata N, Northup PG, Caldwell SH, et al
    Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?
    Transplantation. 2017;101:e281-e282.
    PubMed     Text format    


    July 2017
  72. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Text format     Abstract available


  73. LI Y, Ma D, Wang Z, Yang J, et al
    MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice.
    Transplantation. 2017;101:1600-1608.
    PubMed     Text format     Abstract available


  74. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Text format     Abstract available


  75. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Text format     Abstract available


  76. DESCAMPS V, Brunet-Possenti F
    Human Herpesvirus 6 Reactivation in DRESS With Acute Liver Failure: A Missing Key Factor.
    Transplantation. 2017;101:e224-e225.
    PubMed     Text format    


    June 2017
  77. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.
    PubMed     Text format    


  78. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Text format     Abstract available


    May 2017
  79. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  80. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available


  81. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


    March 2017
  82. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  83. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


    February 2017
  84. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Text format     Abstract available


  85. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Text format     Abstract available


    January 2017
  86. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  87. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


    August 2016
  88. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  89. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  90. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  91. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  92. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  93. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  94. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  95. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  96. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  97. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


    June 2016
  98. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  99. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  100. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


    May 2016
  101. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    March 2016
  102. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  103. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: